[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Page 64021]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-25067]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Noramco, Inc. (GA)

    By Notice dated June 7, 2013, and published in the Federal Register 
on June 20, 2013, 78 FR 37241, Noramco, Inc., 1440 Olympic Drive, 
Athens, Georgia 30601, made application to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of Opium 
Tincture (9630), a basic class of controlled substance listed in 
schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Noramco, Inc., to manufacture the listed basic class of controlled 
substance is consistent with the public interest at this time.
    DEA has investigated Noramco, Inc., to ensure that the company's 
registration is consistent with the public interest. The investigation 
has included inspection and testing of the company's physical security 
systems, verification of the company's compliance with state and local 
laws, and a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.

    Dated: October 10, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-25067 Filed 10-24-13; 8:45 am]
BILLING CODE 4410-09-P